MedTrace Logo

Machine Learning Assessment of Next-Day Migraine Likelihood

NCT07227194 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53065

Last updated 2025-11-12

No results posted yet for this study

Summary

Development of a machine learning (ML) algorithm for assessment of next-day migraine likelihood, drawing on self-reported migraine-related information, and geographic location, collected via the Nerivio app- a mobile application used for migraine treatment by the Remote Electrical Neuromodulation (REN) wearable device.

Conditions

Sponsors & Collaborators

  • WCG IRB

    collaborator UNKNOWN

  • Theranica

    lead INDUSTRY

Principal Investigators

  • Liron Rabany, PhD · Theranica Bio-Electronics ltd

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-07
Primary Completion
2025-08-01
Completion
2025-08-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07227194 on ClinicalTrials.gov